As used in this chapter:
(a) The following terms shall have the following meanings, unless the context clearly indicates that a different meaning is intended:
(1) “Synthetic Cannabinoids” means any material, compound, mixture, or preparation containing any detectable quantity of synthetically produced cannabinoids, their salts, isomers and salts of isomer, unless specifically excepted elsewhere in this section. Since nomenclature of these synthetically produced cannabinoids is not internationally standardized and may continually evolve, these structures or compounds of these structures shall be included under this subsection, regardless of their specific numerical designation of atomic positions covered, so long as it can be determined through some form of scientific testing or analysis that the substance contains properties that fit within one or more of the following categories:
A. Tetrahydrocannabinols: Meaning tetrahydrocannabinols naturally contained in a plant of the genus Cannabis, as well as synthetic equivalents of the substances contained in the plant, or in the resinous extractives of Cannabis, sp. and/or synthetic substances, derivatives and their isomers with similar chemical structure and pharmacological activity such as the following: Delta 1 cis or trans tetrahydrocannabinol, and their optical isomers Delta 6 cis or trans tetrahydrocannabinol, and their optical isomers Delta 3, 4 cis or trans tetrahydrocannabinol and its optical isomers.
B. Naphthoylindoles: Any compound containing a 3-(1-naphthoyl) indole structure with substitution at the nitrogen atom of the indole ring by a alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2piperidinyl) methyl or 2-(4- morpholinyl) ethyl group whether or not further substituted in the indole ring to any extent and whether or not substituted in the naphthyl ring to any extent.
C. Naphthylmethylindoles: Any compound containing a 1H-indol-3-yl- (1-naphyhyl) methane structure with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl) methyl or 2-(4-morpholinyl) ethyl group whether or not further substituted in the indole ring to any extent and whether or not substituted in the naphthyl ring to any extent.
D. Naphthoylpyrroles: Any compound containing a 3-(1-naphthoyl) pyrrole structure with substitution at the nitrogen atom of the pyrrole ring by a alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl) methyl or 2-(4- morpholinly) ethyl group whether or not further substituted in the pyrrole ring to an extent, whether or not substituted in the naphthyl ring to any extent.
E. Naphthylmethylindenes: Any compound containing a naphthylideneindene structure with substitution at the 3-position of the indene ring by a alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl) methyl or 2-(4- morpholinyl) ethyl group whether or not further substitued in the indene ring to any extent, whether or not substituted in the naphthyl ring to any extent.
F. Phenylacetylindoles: Any compound containing a 3- phenylacetylindole structure with substitution at the nitrogen atom of the indole ring by a alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl) methyl or 2-(4- morpholinyl) ethyl group whether or not further substituted in the indole ring to any extent, whether or not substituted in the phenyl ring to any extent.
G. Cyclohexylphenols: Any compound containing a 2-(3- hydroxycyclohexyl) phenol structure with substitution at the 5- position of the phenolic ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinly) methyl or 2-(4-morpholinyl) ethyl group whether or not substituted in the cyclohexyl ring to any extent.
H. Benzoylindoles: Any compound containing a 3-(benzoyl) indole structure with substitution at the nitrogen atom of the indole ring by a alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N- methyl-2-piperidinly) methyl or 2-(4-morpholinyl) ethyl group whether or not further substituted in the indole ring to any extent and whether or not substituted in the phenyl ring to any extent.
I. 2,3-Dihydro-5-methyl-3-(4-morpholinylmethyl) pyrrolo[1,2,3-de]- 1,4 benzoxazin-6-yl]-1-n apthalenylmethanone. Some trade or other names: WIN 55,212-2.
J. Dibenzopyrans including but not limited to (6aR,10aR)-9- (hydroxymethyl)-6, 6-dimethyl-3- (2-methyloctan-2-yl)- 6a,7,10,10a- tetrahydrobenzo[c]chromen-1-ol. Some trade or other names: HU- 210, JWH-051, JWH-139, JWH-161, JWH-229 & JWH-359.
These products include, but are not limited to being contained in preparations such as incense, potpourri, plant fertilizers, insect repellant and are marketed with brand names including but not limited to:
Black Mamba
Dragon Spice
Flash II
Gold Spice
Hush
K2
K3
K4
Kind Spice
Life Spice
Pep Pourri
Space
Spice
Spike
Summit
Voodoo Spice
(2) “Substituted Cathinones” (commonly known as “Bath Salts”) means any compound (except bupropion), mixture or preparation structurally derived from 2-aminopropan-1-one by substitution at the 1-position with either phenyl, naphthyl, or thiophene ring systems, whether or not the compound is modified in any of the following ways:
A. By substitution in the ring system to any extent with alkyl, alkylenedioxy, alkoxy, haloalkyl, hydroxyl, or halide substituents, whether or not further substituted in the ring system by one or more other univalent substituents;
B. By substitution at the 3-position with an acyclic alkyl substitutent;
C. By substitution at the 2-amino nitrogen atom with alkyl, dialkyl, benzyl, or methoxybenzyl groups, or by inclusion of the 2-amino nitrogen atom in a cyclic structure.
These include but are not limited to 3,4-Methylenedioxypyrovalerone (MDPV); 4- methylmethcathinone (mephedrone, 4-MMC), 4-fluromethcathinone (flephedrone), 3,4- methylenedioxymethcathinone (methylone), butylone, and naphyrone. These compounds are often found in a class of novelty products commonly sold as “bath salts.”
These substances are sold with trade names including, but not limited to:
Aura
bk-MBDB
bk-MDMA
Blizzard
Blue Silk
Bonsai Grow
Bonzai Grow
Charge Plus
Cloud 9
Drone
Euphoria
Hurricane Charlie
Ivory Snow
Ivory Wave
Lovey Dovey
Magic
MCAT
MDPK
MDVP
M1
M4
Meph
NRG-1
Ocean
Ocean Burst
PV
POSH
Pure Ivory
Purple Wave
Red Dove
Scarface
Serenity Now
Snow Leopard
Stardust (Star Dust)
Super Coke
Vanilla Sky
White Dove
White Knight
White Lightning
(3) “Manufacture” means the production, preparation, propagation, compounding, conversion or processing of synthetic cannabinoids, synthetic cathinones or other synthetic drugs, either directly or indirectly, by extraction from substances of natural origin, or independently by means of chemical synthesis, and includes any packaging or repackaging of synthetic cannabinoids, synthetic cathinones or other synthetic drugs or labeling of its container, except that this term does not include the preparation, compounding, packaging, or labeling of synthetic cannabinoids, synthetic cathinones or other synthetic drugs as an incident to lawful research, teaching or chemical analysis and not for sale.
(4) “Person” means any individual, corporation, business trust, estate, trust, partnership or association, or any other entity.
(5) “Possession” possession may be either actual or constructive:
A. Actual possession means exercising physical dominion.
B. Constructive possession may be inferred if the defendant has intent and capacity to maintain control and dominion over the synthetic Cannabinoid, Synthetic Cathinone or other synthetic drug or drug paraphernalia.
(6) “Sale” means delivery, barter, exchange, transfer, or gift, or offer thereof, and each transaction of those natures made by any person, whether as principal, proprietor, agent, servant, or employee.
A. It shall be unlawful for any person to knowingly or under circumstances where one reasonably should know, to sell, give, exchange, manufacture, or otherwise distribute to any persons any product containing the substances included in the definition of Synthetic Cannabinoids or Substituted Cathinones or other synthetic drug.
B. It shall be unlawful for any person to knowingly, or under any circumstances where one reasonably should know, to display for sale or possess with intent to distribute any product containing the substances included in the definition of Synthetic Cannabinoids or Synthetic Cathinones or other synthetic drug.
C. It shall be unlawful for any person to use, or to possess with intent to use, ingest, inhale, or otherwise introduce into the human body any product containing the substances included in the definition of Synthetic Cannabinoids or Synthetic Cathinones or other synthetic drug.
D. Whoever violates this section is guilty of using, possessing, or selling Synthetic Cannabinoids, Synthetic Cathinones or other synthetic drug, a misdemeanor of the first degree.
(Ord. 4363. Passed 7-12-11.)